|
|
Analysis of influencing factors of adverse prognosis of continuous renal replacement therapy in critically ill children with acute kidney injury |
GUO Yanmei LI Jun’e SUN Hui HUO Ximin XU Meixian WANG Xiaodong |
The First Department of Critical Care Medicine, Hebei Children’s Hospital, Hebei Province, Shijiazhuang 050031, China |
|
|
Abstract Objective To analyze the influencing factors of adverse prognosis of continuous renal replacement therapy (CRRT) in critically ill children with acute kidney injury. Methods Clinical data of 158 cases with CRRT in critically ill children with acute kidney injury in Hebei Children’s Hospital from January 2017 to December 2019 were retrospectively analyzed. The subjects were followed up for 28 days after entering the pediatric intensive care unit. According to the prognosis, the subjects were divided into the survival group (105 cases) and the death group (53 cases), and the factors affecting the adverse prognosis of CRRT in critically ill children with acute kidney injury were analyzed. Results Septic shock, multiple organ dysfunction, acute kidney injury stage, Serum creatinine (Scr) level at 2 h after admission, urine volume, Scr level before CRRT, cystatin C, microalbuminuria (MAU), transferrin (TRU), α1-microglobulin (α1-MG), N-acetyl-β-D-glucosaminosidase (NAG), acute physiology and chronic health evaluation scoring system Ⅱ (APACHE Ⅱ) score, and estimated glomerular filtration rate (eGFR) between the two groups were compared and the differences were statistically significant (P < 0.05). Septic shock, multiple organ dysfunction, acute kidney injury stage three, Scr level before CRRT≥300.00 μmol/L, cystatin C≥1.00 mg/L, MAU≥7.00 mg/L, α1-MG≥12.00 mg/L, NAG≥24.00 U/L, APACHEⅡ score≥20 points, urine volume<800 mL, and eGFR<100 mL/(min·1.73m2) were risk factors for adverse prognosis of CRRT in critically ill children with acute kidney injury (OR >1, P < 0.05). Conclusion For septic shock, multiple organ dysfunction, acute kidney injury stage three, Scr level before CRRT≥300.00 μmol/L, cystatin C≥1.00 mg/L, MAU≥7.00 mg/L, α1-MG≥12.00 mg/L, NAG≥24.00 U/L, APACHEⅡ score≥20 points, urine volume<800 ml, and eGFR<100 ml/(min·1.73m2) of CRRT in critically ill children with acute kidney injury should be vigilant, active treatment, to reduce the fatality rate of critically ill children with acute kidney injury.
|
|
|
|
|
[1] Xu X,Nie S,Zhang A,et al. Acute Kidney Injury among Hospitalized Children in China [J]. Clin J Am Soc Nephrol,2018,13(12):1791-1800.
[2] Romagnoli S,Ricci Z,Ronco C. CRRT for sepsis-induced acute kidney injury [J]. Curr Opin Crit Care,2018,24(6):483-492.
[3] Karkar A. Continuous renal replacement therapy:Principles,modalities,and prescription [J]. Saudi J Kidney Dis Transpl,2019,30(6):1201-1209.
[4] Khwaja A. KDIGO clinical practice guidelines for acute kidney injury [J]. Nephron Clin Pract,2012,120(4):179-184.
[5] Hoste EAJ,Kellum JA,Selby NM,et al. Global epidemiology and outcomes of acute kidney injury [J]. Nat Rev Nephrol,2018,14(10):607-625.
[6] Fitzgerald JC,Ross ME,Thomas NJ,et al. Risk factors and inpatient outcomes associated with acute kidney injury at pediatric severe sepsis presentation [J]. Pediatr Nephrol,2018,33(10):1781-1790.
[7] Hessey E,Morissette G,Lacroix J,et al. Long-term Mortality After Acute Kidney Injury in the Pediatric ICU [J]. Hosp Pediatr,2018,8(5):260-268.
[8] 王利利,赵忠秀,张新庆.儿童脓毒症并发急性肾损伤及其预后的危险因素[J].儿科药学杂志,2020,26(10):8-10.
[9] Rhee H,Jang GS,An YJ,et al. Long-term outcomes in acute kidney injury patients who underwent continuous renal replacement therapy:a single-center experience [J]. Clin Exp Nephrol,2018,22(6):1411-1419.
[10] 张毅,谢坚,刘亚琼,等.影响儿童重症病房新生儿发生急性肾损伤及预后相关因素分析[J].现代生物医学进展,2016,16(24):4698-4701.
[11] Al-Hwiesh A,Abdul-Rahman I,Finkelstein F,et al. Acute Kidney Injury in Critically Ill Patients:A Prospective Randomized Study of Tidal Peritoneal Dialysis Versus Continuous Renal Replacement Therapy [J]. Ther Apher Dial,2018,22(4):371-379.
[12] 池锐彬,邹启明,李超锋,等.不同时刻血肌酐水平对危重症患者急性肾损伤预后的影响[J].中华急诊医学杂志,2019,28(9):1083-1087.
[13] 臧学峰,古旭云,赵磊,等.尿微量白蛋白及尿α1-微球蛋白对严重脓毒症患者急性肾损伤早期诊断价值[J].中国实验诊断学,2018,22(6):1006-1009.
[14] 丁国雷,练睿,袁烁.连续性肾脏替代治疗时机对脓毒性休克伴急性肾损伤患者预后的影响[J].中日友好医院学报,2019,33(6):346-348.
[15] Lee JH,Jung JY,Park SW,et al. Risk factors of acute kidney injury in children after cardiac surgery [J]. Acta Anaesthesiol Scand,2018,62(10):1374-1382.
[16] 刘连凤,李敏,于永慧,等.儿童严重脓毒症并MODS临床特征及预后因素分析[J].湖南中医药大学学报,2012, 32(8):45-47.
[17] 张会芬,杨宏秀,刘丽,等.血清中性粒细胞明胶酶相关脂质运载蛋白、胱抑素C及尿白蛋白肌酐比值、N-乙酰-β-D-氨基葡萄糖苷酶检测在早期糖尿病肾脏疾病中的应用价值[J].中国糖尿病杂志,2018,26(4):309-315.
[18] Zinter MS,Spicer AC,Liu KD,et al. Positive Cumulative Fluid Balance Is Associated With Mortality in Pediatric Acute Respiratory Distress Syndrome in the Setting of Acute Kidney Injury [J]. Pediatr Crit Care Med,2019,20(4):323-331.
[19] 张丽亚,陈黎丽,罗芳.尿IL-18、转铁蛋白和β2微球蛋白在新生儿窒息致急性肾损伤早期诊断中的价值[J].浙江医学,2019,41(18):1932-1937.
[20] 叶照伟,蔡立华,沈利汉.胱抑素C在脓毒症相关的急性肾损伤中的诊断价值[J].中国医药科学,2019,9(9):190-193.
[21] 池锐锋,林冰薇,林喜春.清蛋白、胱抑素C及胆红素联合检测在急性脑梗死合并急性肾损伤中的预测价值[J].中国当代医药,2020,27(8):48-50,55.
[22] Miao H,Shi J,Wang C,et al. Continuous Renal Replacement Therapy in Pediatric Severe Sepsis:A Propensity Score-Matched Prospective Multicenter Cohort Study in the PICU [J]. Crit Care Med,2019,47(10):e806-e813.
[23] Cleto-Yamane TL,Gomes CLR,Suassuna JHR,et al. Acute Kidney Injury Epidemiology in pediatrics [J]. J Bras Nefrol,2019,41(2):275-283.
[24] Serna-Higuita LM,Nieto-Ríos JF,Contreras-Saldarriaga JE,et al. Risk factors for acute kidney injury in a pediatric intensive care unit:a retrospective cohort study [J]. Medwave,2017,17(3):e6940.
[25] 谢东德,郭翼华,熊艳明,等.尿胱抑素C和NAG联合检测在早期肾小管损伤的应用价值[J].检验医学与临床,2017,14(21):3252-3254.
[26] 徐海霞,邵晓珊,李宇红,等.儿童急性肾损伤肾脏替代治疗不良预后因素分析[J].中华儿科杂志,2020,58(9):725-730.
[27] 黄永鹏,谢文杰,叶燕红,等.连续肾脏替代治疗对急性肾损伤患者巨噬细胞及相关细胞因子的影响[J].中外医学研究,2021,19(14):24-26.
[28] 韩佳滨,岳桂芳,郑露,等.CRRT治疗脓毒症休克并发急性肾损伤的临床效果[J].中国现代医生,2020,58(19):107-109,114. |
|
|
|